Myrexis, Inc. (MYRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0070
0.00 (0.00%)
At close: Jan 17, 2025
Myrexis Company Description
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets.
The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010.
Myrexis, Inc. is headquartered in New York, New York.
Myrexis, Inc.
| Country | United States |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 1 |
| CEO | Jonathan Couchman |
Contact Details
Address: 630 Fifth Avenue New York, Delaware 10020 United States | |
| Phone | 801-214-7800 |
| Website | myrexis.com |
Stock Details
| Ticker Symbol | MYRX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | US62856H1077 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jonathan M. Couchman CFA | Chairman, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer |